Holen Sie sich die Stockscreener-App
6.95
0.57%
-0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$6.99
Offen:
$6.95
24-Stunden-Volumen:
1.39M
Relative Volume:
0.57
Marktkapitalisierung:
$2.58B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-14.48
EPS:
-0.48
Netto-Cashflow:
$1.01B
1W Leistung:
-3.20%
1M Leistung:
+9.45%
6M Leistung:
+4.35%
1J Leistung:
-13.77%
1-Tages-Spanne:
$6.87
$7.02
1-Wochen-Bereich:
$6.87
$7.25
52-Wochen-Spanne:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.95 | 2.59B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
125.82 | 55.71B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.59 | 49.38B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.11 | 44.89B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.21 | 35.96B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
487.25 | 21.36B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Japan Dermatology Devices Market is Driven by Skin Health - openPR.com
Bausch Health Signs Multiple Material Agreements - TradingView — Track All Markets
Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst - MarketBeat
What is Zacks Research's Estimate for TSE:BHC Q4 Earnings? - MarketBeat
Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt ExchangeHas The Bull Case Changed? - Yahoo Finance
Bausch Health announces completion of $1.6 billion debt exchange offer By Investing.com - Investing.com Nigeria
Bausch Health announces completion of $1.6 billion debt exchange offer - Investing.com
Bausch Health Announces Final Results and Expiration of Exchange Offers - ACCESS Newswire
Bausch Health Companies Inc Announces Final Results of Exchange Offers - TradingView — Track All Markets
Bausch Health Cos (NYSE:BHC) Trading Up 4.9%Time to Buy? - MarketBeat
Beauty Devices Markets, Competition and Regional Analysis - GlobeNewswire
Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO and More - Yahoo Finance
Bausch Health’s Large 2032 Debt Exchange Might Change The Case For Investing In Bausch Health (BHC) - simplywall.st
Is Bausch Health Companies Inc. (BVF) stock dividend growth reliableBear Alert & Daily Profit Maximizing Trade Tips - ulpravda.ru
Bausch Health (NYSE:BHC) Valuation Check After Strong Early Uptake of New 2032 Note Exchange Offer - Sahm
Is Bausch Health a Contrarian Opportunity After Its Recent Price Rebound and DCF Valuation Gap - Sahm
Why Bausch Health Companies Inc. stock is in analyst buy zone2025 Major Catalysts & Intraday High Probability Setup Alerts - DonanımHaber
How Bausch Health Companies Inc. stock performs in rising dollar environmentWeekly Stock Recap & Daily Entry Point Trade Alerts - Улправда
How Bausch Health Companies Inc. stock expands through international marketsJuly 2025 Pullbacks & Low Risk Investment Opportunities - DonanımHaber
Bausch + Lomb appoints two new directors to board effective January By Investing.com - Investing.com Nigeria
Bausch + Lomb appoints two new directors to board effective January - Investing.com
Bausch Health Companies (TSE:BHC) Raised to "Hold" at Raymond James Financial - MarketBeat
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Bausch Health Cos (NYSE:BHC) Raised to Hold at Raymond James Financial - MarketBeat
Icahn Money Manager Sues His Bosses and Bausch + Lomb Over Anti-White Bias - Bloomberg.com
Laser Therapy Devices Market Is Going to Boom |• Abbott • Bausch Health Companies - openPR.com
Nomura Holdings Inc. Sells 1,900,000 Shares of Bausch Health Cos Inc. $BHC - MarketBeat
Retail Trends: Why Bausch Health Companies Inc stock is in analyst buy zoneJuly 2025 Weekly Recap & Stepwise Trade Execution Plans - moha.gov.vn
Bausch + Lomb allocates $2.8 billion to refinance outstanding loans By Investing.com - Investing.com Nigeria
Bausch + Lomb allocates $2.8 bln in new term loans to refinance existing debt - MSN
Bausch Health Companies Inc Refinances Term B Loans - TradingView — Track All Markets
Bausch + Lomb allocates $2.8 billion to refinance outstanding loans - Investing.com
Bausch Health (NYSE: BHC) to refinance $2.80B Bausch + Lomb term loans with lower margins - Stock Titan
Maple Rock Capital Partners Inc. Has $52.01 Million Holdings in Bausch Health Cos Inc. $BHC - MarketBeat
Bausch Health Cos Inc. $BHC Stock Holdings Lifted by Paulson & CO. Inc. - MarketBeat
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake - AOL.com
Stock Recap: How Bausch Health Companies Inc stock benefits from global expansionJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - moha.gov.vn
Barclays Initiates Coverage on Bausch Health Cos (NYSE:BHC) - MarketBeat
Bausch Health Companies (TSE:BHC) Upgraded at Barclays - MarketBeat
Bausch Health Cos Inc. $BHC Holdings Reduced by Arrowstreet Capital Limited Partnership - MarketBeat
Barclays Initiates Coverage of Bausch Health Companies (BHC) with Equal-Weight Recommendation - Nasdaq
BHC: Barclays Initiates Coverage with Equal-Weight Rating | BHC Stock News - GuruFocus
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Bausch Health Companies Inc Announces Early Exchange Offer Results - TradingView — Track All Markets
Bausch Health (NYSE:BHC) expects $1.6 billion of new 2032 notes in senior debt exchange - Stock Titan
Bausch Health Announces Early Exchange Offer Results for Exchange Offers - Yahoo Finance
Why Bausch Health (BHC) Is Up 9.1% After John Paulson Deepens His Stake – And What's Next - Sahm
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Why Investors Shouldn't Be Surprised By Bausch Health Companies Inc.'s (NYSE:BHC) Low P/S - 富途牛牛
Bausch Health ticks higher following large director stock purchase - MSN
Is Bausch Health Companies Inc. (BVF) stock a buy before earnings resultsOptions Play & Free Community Supported Trade Ideas - Newser
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.30%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):